The role of positron emission tomography (PET) in the management of lymphoma patients
Open Access
- 1 October 1999
- journal article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 10 (10), 1181-1184
- https://doi.org/10.1023/a:1008327127033
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s diseaseAnnals Of Oncology, 1998
- Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Extranodal malignant lymphoma: detection with FDG PET versus CT.Radiology, 1998
- High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell LymphomaNew England Journal of Medicine, 1997
- 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphomaNuclear Medicine Communications, 1997
- Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.Journal of Clinical Oncology, 1997
- Magnetic resonance imaging and67ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot studyMagnetic Resonance Materials in Physics, Biology and Medicine, 1996
- Monitoring Bulky Mediastinal Disease with Gallium-67, CT-Scan and Magnetic Resonance Imaging in Hodgkin's Disease and High-Grade Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1996
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- PET and [11C]methionine in assessment of response in non-Hodgkin lymphomaThe Lancet, 1990